MorphoSys AG (MOR, MPSYY.PK) reported third-quarter consolidated net result of 30.2 million euros compared to a negative net result of 24.0 million euros, previous year. Basic earnings per share was 0.96 euros compared to a loss of 0.83 euros. EBIT was 30.1 million euros compared to a negative EBIT of 23.5 million euros, reflecting in particular the up-front payment made by Novartis under the MOR106 license agreement.
from RTT - Earnings https://ift.tt/2D55Afy
via IFTTT
No comments:
Post a Comment